Ann: Midkine Symposium Munich, page-43

Cellmid's LMU collaboration might be up to something. Here is a recent post by one of their researchers about their findings from earlier this year.

Midkine controls natural bypass growth by regulating the bioavailability of VEGF

"...midkine might present a drug superior to currently available vasodilators such as nitric oxide donors, which only show a limited effect due to rapid tolerance."

https://atlasofscience.org/midkine-controls-natural-bypass-growth-by-regulating-the-bioavailability-of-vegf/

The Atlas of Science: is made by scientists for scientists. The aim of the project is publishing layman's abstracts of research articles.